Michael Wiggins De Oliveira, author at Seeking Alpha, discusses health supplement retailer GNC as his "Idea of the Month."
He notes that even though the company is in debt by more than $1 billion, it's still a buy for him because of the measures the company is taking to wipe out the debt, including the $200 million in annual free cash flow.
Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection.
ReturnPro CEO Sender Shamiss to discuss how his company is changing the way we make returns and how Trump's tariffs are affecting the return business. Watch!
Walmart, which became the nation’s largest retailer by making low prices a priority, has found itself in a place it’s rarely been: Warning customers that prices will rise for goods ranging from bananas to car seats.
Chris Beauchamp, Chief Market Analyst at IG International, joins J.D. Durkin to give analysis on the recent trade truce between the U.S. and China. Watch!